31-P nuclear magnetic resonance studies on serum low and high density lipoproteins: effect of paramagnetic ion.

A paramagnetic quenching reagent, Mn-2+/EDTA (1:2.2), was developed for the purpose of investigating the phospholipid phosphate groupings of human serum low and high density lipoproteins through the quenching effect of the reagent on the 31-P nuclear magnetic resonance signals from these complexes. Systems investigated included native low and high density serum liproteins (LDL, HDL2, and HDL3), egg phosphatidylcholine vesicles together with appropriate phosphodiester model systems, diethyl phosphate in aqueous buffer, and phosphatidylcholine and sphingomyelin both in anhydrous methanol. The results of these studies indicated that ca. 50 percent of the phospholipid-phosphorus signal of LDL is quenched upon titration as compared to an 80-85 percent figure observed for HDL2 and HDL3. In all cases the spectral effects were totally reversible upon removalof the paramagnetic ion by dialysis. The results of the titration studies indicated a similar but not an identical behavior between HDL2 and HDL3. The results are consistent with model structures of HDL and LDL particles derived from low angle X-ray diffraction.

[1]  W. Stoffel,et al.  13C nuclear magnetic resonance spectroscopic evidence for hydrophobic lipid-protein interactions in human high density lipoproteins. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[2]  G. Assmann,et al.  31P nuclear magnetic resonance spectroscopy of native and recombined lipoproteins. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[3]  A. Omachi,et al.  Phosphate metabolism in intact human erythrocytes: determination by phosphorus-31 nuclear magnetic resonance spectroscopy. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[4]  A. Scanu,et al.  31P nuclear magnetic resonance: application to the study of human serum high density lipoproteins. , 1974, Biochimica et biophysica acta.

[5]  G. Assmann,et al.  A molecular model of high density lipoproteins. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[6]  A. Scanu,et al.  A study of the abnormal lipoproteins in abetalipoproteinemia. , 1974, The Journal of clinical investigation.

[7]  T. Glonek,et al.  Phosphorus-31 nuclear magnetic resonance spectroscopy of phospholipids. , 1974, Biochemistry.

[8]  D. Michaelson,et al.  Transbilayer asymmetry and surface homogeneity of mixed phospholipids in cosonicated vesicles. , 1973, Biochemistry.

[9]  V. Luzzati,et al.  On the structure of human serum low density lipoprotein. , 1972, Journal of molecular biology.

[10]  A. Scanu.  STRUCTURE OF HUMAN SERUM LIPOPROTEINS , 1972, Annals of the New York Academy of Sciences.

[11]  M. Webber.  International Encyclopedia of Pharmacology and Therapeutics , 1972 .

[12]  T. Glonek,et al.  Phosphorus-31 nuclear magnetic resonance studies of the phosphonate and phosphate composition of the sea anemone, Bunadosoma, sp. , 1972, Archives of biochemistry and biophysics.

[13]  V. Bystrov,et al.  NMR differentiation of the internal and external phospholipid membrane surfaces using paramagnetic Mn2+ and Eu3+ ions , 1971 .

[14]  T. Glonek,et al.  Studies of biological polyphosphate through the use of phosphorus-31 nuclear magnetic resonance. , 1971, Archives of biochemistry and biophysics.

[15]  T. Glonek,et al.  Biological Phosphonates: Determination by Phosphorus-31 Nuclear Magnetic Resonance , 1970, Science.

[16]  A. Gotto.  Recent studies on the structure of human serum low-and high-density lipoproteins. , 1969, Proceedings of the National Academy of Sciences of the United States of America.

[17]  A. Gotto,et al.  Application of electron spin resonance to the study of the structure of human serum lipoproteins. , 1969, Biochemical and biophysical research communications.

[18]  C. C. Hinckley.  Paramagnetic shifts in solutions of cholesterol and the dipyridine adduct of trisdipivalomethanatoeuropium. 3. A shift reagent. , 1969, Journal of the American Chemical Society.

[19]  A. Scanu,et al.  High-resolution NMR spectra of high-density serum lipoproteins. , 1969, Biochimica et biophysica acta.

[20]  A. Scanu,et al.  Nuclear magnetic resonance studies of serum low density lipoproteins (LDL2) , 1969 .

[21]  J. Steim,et al.  Structure of Human Serum Lipoproteins: Nuclear Magnetic Resonance Supports a Micellar Model , 1968, Science.

[22]  A. Gotto,et al.  The structure and properties of human beta-lipoprotein and beta-apoprotein. , 1968, Biochemical and biophysical research communications.

[23]  A. Scanu,et al.  On the structure of human serum high-density lipoprotein: studies by the technique of circular dichroism. , 1968, Proceedings of the National Academy of Sciences of the United States of America.

[24]  V. P. Skipski,et al.  Lipid composition of human serum lipoproteins. , 1967, The Biochemical journal.

[25]  J. R. Wazer,et al.  Metal Complexing By Phosphates , 1958 .

[26]  M. Ritter,et al.  The proteins of plasma lipoproteins: properties and significance. , 1973, Advances in clinical chemistry.

[27]  A. Scanu,et al.  Serum lipoproteins structure and function. , 1972, Annual review of biochemistry.

[28]  G. Shipley,et al.  Small-angle x-ray scattering of human serum high-density lipoproteins. , 1972, Journal of supramolecular structure.

[29]  Ching-Hsien Huang,et al.  Phosphatidylcholine vesicles. Formation and physical characteristics , 1969 .